BACKGROUND: A rapidly progressive phenotype of Alzheimer's disease (AD) has been described in some prion disease cohorts. Limited information regarding rapidly progressive AD (rpAD) is available from longitudinal national cohorts. OBJECTIVE: To compare the clinical characteristics of rpAD in two different national cohorts. METHODS: A retrospective analysis was performed on AD subjects with available neuropathology in the National Alzheimer's Coordinating Center (NACC) database and among neuropathologically characterized AD cases from the National Prion Disease Pathology Surveillance Center (NPDPSC) that were evaluated for suspected prion disease. In the NACC cohort, rpAD was delineated by the lower 10th percentile of follow up duration from pre-dementia to death duration among subjects meeting pathological diagnosis of AD. RESULTS: rpAD from the NPDPSC had a shorter mean symptom duration than the NACC identified rpAD cases (11.6 months versus 62.4 months) and were also younger at the time of their death (60.0 versus 81.8 years). NACC identified rpAD subjects, beginning from a predementia stage, had slower rate of MMSE change per year than NPDPSC cases (2.5 versus 6.0 points). CONCLUSIONS: rpAD constitute an important subset of AD subjects in whom a rapid course of symptomatic clinical decline is noted, as confirmed in both national cohorts. rpAD was best characterized by survival time (≤3 years), as there were clear differences between the rpAD cohorts in terms of symptom duration, age at death, and MMSE change per year, likely due to the strong selection biases. rpAD could shed light on the biology of rate of progression in AD.
BACKGROUND: A rapidly progressive phenotype of Alzheimer's disease (AD) has been described in some prion disease cohorts. Limited information regarding rapidly progressive AD (rpAD) is available from longitudinal national cohorts. OBJECTIVE: To compare the clinical characteristics of rpAD in two different national cohorts. METHODS: A retrospective analysis was performed on AD subjects with available neuropathology in the National Alzheimer's Coordinating Center (NACC) database and among neuropathologically characterized AD cases from the National Prion Disease Pathology Surveillance Center (NPDPSC) that were evaluated for suspected prion disease. In the NACC cohort, rpAD was delineated by the lower 10th percentile of follow up duration from pre-dementia to death duration among subjects meeting pathological diagnosis of AD. RESULTS: rpAD from the NPDPSC had a shorter mean symptom duration than the NACC identified rpAD cases (11.6 months versus 62.4 months) and were also younger at the time of their death (60.0 versus 81.8 years). NACC identified rpAD subjects, beginning from a predementia stage, had slower rate of MMSE change per year than NPDPSC cases (2.5 versus 6.0 points). CONCLUSIONS: rpAD constitute an important subset of AD subjects in whom a rapid course of symptomatic clinical decline is noted, as confirmed in both national cohorts. rpAD was best characterized by survival time (≤3 years), as there were clear differences between the rpAD cohorts in terms of symptom duration, age at death, and MMSE change per year, likely due to the strong selection biases. rpAD could shed light on the biology of rate of progression in AD.
Entities:
Keywords:
Alzheimer’s disease; dementia; rapidly progressive dementia; rate of decline
Authors: Chae Kim; Tracy Haldiman; Sang-Gyun Kang; Lenka Hromadkova; Zhuang Zhuang Han; Wei Chen; Frances Lissemore; Alan Lerner; Rohan de Silva; Mark L Cohen; David Westaway; Jiri G Safar Journal: Sci Transl Med Date: 2022-01-05 Impact factor: 19.319
Authors: Jagan A Pillai; James Bena; Gurkan Bebek; Lynn M Bekris; Aaron Bonner-Jackson; Lei Kou; Akshay Pai; Lauge Sørensen; Mads Neilsen; Stephen M Rao; Mark Chance; Bruce T Lamb; James B Leverenz Journal: Ann Clin Transl Neurol Date: 2020-07-07 Impact factor: 4.511
Authors: Cristina Basso; Fiorella Calabrese; Marta Sbaraglia; Claudia Del Vecchio; Giovanni Carretta; Annamaria Saieva; Daniele Donato; Luciano Flor; Andrea Crisanti; Angelo Paolo Dei Tos Journal: Virchows Arch Date: 2020-06-09 Impact factor: 4.535